http://www.maunakeatech.com/ Wed, 19 Jun 2013 10:40:24 +0100 http://www.maunakeatech.com/sites/all/themes/mkt/image/site/logo.jpg http://www.maunakeatech.com/ BRONX AGENCE http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 18 Jun 2013 14:12:19 +0100 Endo-update 2013 is a two-day interventional endoscopy update course in Augsburg, Germany, with an internationally recognized faculty highlighting the latest research, skills, and technologies with simultaneous live sessions, state-of-the-art lectures, case discussions and interactive case presentations. More details to come soon !

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Wed, 10 Apr 2013 16:18:49 +0100 The World Molecular Imaging Congress is organized by the joint efforts of the “World Molecular Imaging Society – WMIS“, the “European Society for Molecular Imaging – ESMI” and the “Federation of Asian Societies for Molecular Imaging – FASMI“. The WMIC is led by the senior academic and industry professionals who have widely recognized expertise in molecular imaging. The scientific sessions held at the conference cover a broad spectrum of basic and translational sciences (pre-clinical to clinical) forming a Discovery-to-Delivery (D2D) process that helps facilitate academic and industrial partnerships. Through innovation, our goal is to optimize the D2D efforts leading to new medical and molecular imaging discoveries, greater linkages between research and market outcomes, and significant improvements in healthcare. Comme visit us and discover Cellvizio Dual Band for translational research!

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 18 Jun 2013 11:48:51 +0100 The biannual meeting of the European Group for Endoscopic Ultrasonography (EGEUS) will be held in Istanbul. The Congress will be organized in collaboration with the Turkish Society of Gastrointestinal Endoscopy. Attend our live video demonstration showing needle-based confocal laser endomicroscopy (nCLE).

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:33:04 +0100 The BSG Annual Meeting will take place this year at the Scottish Exhibition and Conference Centre (SECC), Glasgow. We hope that you will be able to be a part of this multidisciplinary meeting covering all aspects of medical and surgical gastroenterology and hepatology with cutting edge clinical and basic science research. Visit our distributor SynMed Ltd at Hall 4, Booth #A1, and turn to optical biopsy with Cellvizio.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:22:21 +0100 The 31st GEEW will take place at the Brussels Exhibition Centre. It will include live video demonstrations permitting interchanges between faculty and registrants during procedures, lectures and quizzes. The audio-visual transmission will be broadcast live from the Erasme Hospital, and each procedure will be performed by international expert physicians. Please visit us at Hall 10, Booth #11. You are also cordially welcomed to attend the Cellvizio live demonstrations (Auditorium 2000), including ERCP and EUS-FNA procedures. Simultaneous translation into French will be provided.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Fri, 24 May 2013 16:26:00 +0100 Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Mon, 17 Jun 2013 10:43:57 +0100 PARIS, (June 13, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported that it has entered an exclusive distribution agreement in Japan with AMCO Inc. for a five-year period. This partnership further strengthens Mauna Kea Technologies’ ties with the Japanese market, and is a major step forward in the company’s efforts to obtain regulatory approval in the world’s second largest endoscopy device market after the US. The Japanese Ministry of Health, Labor, and Welfare (MHLW) requires foreign medical device companies to have a physical presence within the country or define a partnering distributor prior to approving a device for commercial sale.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Fri, 24 May 2013 16:26:55 +0100 http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Fri, 24 May 2013 16:27:40 +0100 Learn how Optical Biopsy will improve your practice, understand how Cellvizio system works, Achieve a basic understanding of Cellvizio image interpretation,observe live cases and review case studies.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 17 Jun 2013 12:23:32 +0100 In IDEN 2013, the two days impressive scientific program will deal with a wide variety of concerns from upper GI, lower GI and pancreatobiliary endoscopy. IDEN 2013 is also an excellent opportunity to exchange advanced knowledge of the latest issues on endoscopy with experts from around the world.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Fri, 24 May 2013 16:29:07 +0100 Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Thu, 23 May 2013 11:32:58 +0100 Understand how the Cellvizio system works and achieve basic Cellvizio image interpretation skills. Live cases will be observed.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Wed, 10 Apr 2013 17:52:28 +0100 As in previous years, this high-level meeting will foster the strong network of the (European) Molecular Imaging Community. EMIM 2013 will bring together top scientists from various disciplines, working in diverse fields of Molecular Imaging, provide a platform for knowledge exchange between the disciplines, "generations", and societies, strengthen the interaction between the groups and everybody who is sharing our vision that interdisciplinary knowledge exchange is the basis for innovation...
 

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Wed, 22 May 2013 17:46:38 +0100 ORLANDO (May 22, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that optical biopsies using a microscope so tiny it fits through a small needle show clear cellular-level images inside pancreatic cysts, which could assist physicians in the diagnosis of pancreatic cystic tumors and help patients with benign cysts avoid unnecessary surgery, according to new data presented at Digestive Disease Week 2013, which concludes here today.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:04:56 +0100 Digestive Disease Week® (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Thu, 11 Apr 2013 16:31:01 +0100 Learn how Optical Biopsy will improve your practice, understand how Cellvizio system works, Achieve a basic understanding of Cellvizio image interpretation,observe live cases and review case studies.

]]> http://www.maunakeatech.com/mktlive/newsletter http://www.maunakeatech.com/mktlive/newsletter Tue, 07 May 2013 09:58:58 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 30 Apr 2013 10:10:14 +0100 PARIS, April 30, 2013 – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ-­â€FlexTM 19 miniprobe to provide real-­â€time optical biopsies during endoscopic ultrasound-­â€guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio or one of its dedicated miniprobes, which already obtained the CE mark in Europe.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Fri, 15 Mar 2013 11:38:49 +0100 Chaired by Dr. Marc Giovannini, the 10th European Congress of Endoscopic ultrasonography will take place in Paris from 25 to 26 April 2013. The local and invited guest faculty includes internationally recognized experts in endoscopic ultrasonography. New EUS guided therapies will be demonstrated from Marseille (Paoli-Calmettes Institute), but also new diagnostic technique using needle-based confocal laser endomicroscopy (nCLE).

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 17 Dec 2012 17:17:59 +0100 This course will provide the latest innovations in the management of gastrointestinal diseases and disorders, and a unique opportunity to learn more about the latest interventional and surgical procedures, featuring hands-on animal tissue labs allowing for safe practice.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 23 Apr 2013 17:44:41 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 18 Mar 2013 16:29:59 +0100 The field of endoscopy has rapidly evolved with the introduction of innovative diagnostic techniques and novel therapies. The endoscopist frequently encounters difficult issues and controversies in patient management. This program is designed to take a case-based and endoscopic video approach to understand the current role of endoscopy in the care of patients with a variety of gastrointestinal diseases.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Thu, 23 May 2013 11:51:39 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Wed, 17 Apr 2013 09:45:10 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 26 Mar 2013 16:58:03 +0100 The field of endoscopy has burgeoned from the ability to simply look at the lining of the GI tract with the scope to the current advanced technology which not only allows interventional gastroenterologists to obtain detailed images but also use the scope as a tool for treatment. Visualization has gone beyond looking at the surface and delved deeper to obtain ultrasound and microscopic images. Diagnostic capabilities have improved to allow for tissue acquisition in challenging anatomy with ERCP, cholangiopancreatoscopy, EUS, and double balloon endoscopy. Surgeons and oncologists increasingly rely on interventional gastroenterologists for appropriate diagnosis, staging and often management of GI neoplasms. Endoscopy has emerged as a less invasive alternative to surgery in the areas of endoscopic mucosal resection, tissue ablation, pancreatic pseudocyst drainage, and now even achalasia therapy. All of these new frontiers of endoscopy are rapidly evolving. This course will outline where standard practices in endoscopy are currently and how new innovations may enhance or revolutionize endoscopic practice in the future.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Thu, 11 Apr 2013 17:22:13 +0100 PARIS (April 10, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that the first Cellvizio system was sold in China, one of the fastest growing, largest medical device markets in the world. Yan-Qing Li, MD, Professor of Gastroenterology at Shandong University, Qilu Hospital, a pioneer in the optical biopsy field in China and a prolific researcher on applications of endomicroscopy, will be a key resource for the education efforts in China.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 26 Mar 2013 17:54:48 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 26 Mar 2013 16:45:07 +0100 PARIS (March 21, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world. Previous studies have shown that Cellvizio’s real-time, cellular-level views of distal lung tissue extend the reach and improve the diagnostic accuracy of bronchoscopy procedures, reducing the need to repeat invasive, expensive diagnostic tests.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 15 Jan 2013 09:47:54 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 16:29:48 +0100 A French-speaking congress of reference in terms of digestive cancers and diseases gathering 4000 participants each year.

]]>